Autori: Papanas Nikolaos
Naslov | Circulating follistatin as a novel biomarker of type 2 diabetes mellitus risk (Letter) |
Autori | Papachristou Stella Popovic Djordje S Papanas Nikolaos |
Info | INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, (2023), vol. 43 br. 5, str. 779-780 |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: |
Naslov | Glucagon-like peptide-1 receptor agonists for improving cardiorenal outcomes in type 1 diabetes mellitus? (Letter) |
Autori | Popovic Djordje S Stoian Anca Pantea Papanas Nikolaos |
Info | ENDOCRINE, (2023), vol. 80 br. 1, str. 232-233 |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
Naslov | Beta-Catenin Signaling Pathway: Perhaps We Should Start Exploring it for Diabetic Foot Ulcer Healing? (Article) |
Autori | Papanas Nikolaos Popovic Djordje S |
Info | INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, (2023), vol. 22 br. 3, str. 441-443 |
Projekat | Eli Lilly; MSD; Novo Nordisk; Novartis; Sanofi-Aventis; TrigoCare International; AstraZeneca; Boehringer Ingelheim |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
Naslov | Post COVID-19 syndrome related to diabetes - A brief review (Review) |
Autori | Stoian Anca Pantea Rizzo M Salmen T Kempler Peter Stulnig T Papanas Nikolaos Popovic Djordje S Herder C Serban D |
Info | DIABETES STOFFWECHSEL UND HERZ, (2022), vol. 31 br. 2, str. 126-130 |
Ispravka | ISI/Web of Science Elečas Rang časopisa |
Naslov | Could cardiorenal benefits of sodium-glucose co-transporter 2 inhibitors be extended to type 1 diabetes mellitus? (Letter) |
Autori | Popovic Djordje S Stoian Anca Pantea Papanas Nikolaos |
Info | JOURNAL OF DIABETES AND ITS COMPLICATIONS, (2022), vol. 36 br. 11, str. - |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
Naslov | Ezetimibe and Insulin Resistance (Editorial Material) |
Autori | Popovic Djordje S Papachristou Stella Stokic Edita J Papanas Nikolaos |
Info | CURRENT VASCULAR PHARMACOLOGY, (2022), vol. 20 br. 4, str. 315-317 |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
Naslov | Achieving LDL-cholesterol Targets: How Good are we in the Balkan Region? (Editorial Material) |
Autori | Popovic Djordje S Stokic Edita J Stoian Anca Pantea Papanas Nikolaos |
Info | CURRENT VASCULAR PHARMACOLOGY, (2022), vol. 20 br. 4, str. 311-312 |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
Naslov | Immune checkpoint inhibitors-induced diabetes mellitus: a growing clinical presentation requiring our attention (Editorial Material) |
Autori | Popovic Djordje S Koufakis Theocharis Kovacevic Bojan Rizzo Manfredi Papanas Nikolaos |
Info | EXPERT OPINION ON DRUG SAFETY, (2022), vol. 21 br. 11, str. 1337-1339 |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
Naslov | Translating results from the cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists into clinical practice: Recommendations from a Eastern and Southern Europe diabetes expert group (Article) |
Autori | Janez Andrej Muzurovic Emir Stoian Anca Pantea Haluzik Martin Guja Cristian Czupryniak Leszek Duvnjak Lea Lalic Nebojsa M Tankova Tsvetalina Bogdanski Pawel Papanas Nikolaos Nunes Jose Silva Kempler Peter Fras Zlatko Rizzo Manfredi |
Info | INTERNATIONAL JOURNAL OF CARDIOLOGY, (2022), vol. 365 br. , str. 8-18 |
Projekat | Novo Nordisk |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
Naslov | Double Diabetes: A Growing Problem Requiring Solutions (Article) |
Autori | Popovic Djordje S Papanas Nikolaos |
Info | EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, (2022), vol. 130 br. 04, str. 268-274 |
Projekat | Eli LillyEli Lilly; MSD; Novo NordiskNovo Nordisk; NovartisNovartis; Sanofi-AventisSanofi-Aventis |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |